2020-03-08 Atul Butte's keynote for the AMIA Virtual Informatics Summit
Atul Butte's AAPS big data workshop presentation 6/2015
1. Open Big Data in Biomedicine
Atul Butte, MD, PhD
Director, Institute for
Computational Health Science
University of California, San Francisco
atul.butte@ucsf.edu
@atulbutte
@ImmPortDB
2. Disclosures
• Scientific founder and
advisory board membership
– Genstruct
– NuMedii
– Personalis
– Carmenta
• Honoraria for talks
– Lilly
– Pfizer
– Siemens
– Bristol Myers Squibb
– AstraZeneca
– Roche
– Genentech
– Warburg Pincus
• Past or present consultancy
– Lilly
– Johnson and Johnson
– Roche
– NuMedii
– Genstruct
– Tercica
– Ecoeos
– Ansh Labs
– Prevendia
– Samsung
– Assay Depot
– Regeneron
– Verinata
– Pathway Diagnostics
– Geisinger Health
– Covance
– Wilson Sonsini Goodrich & Rosati
– 10X Genomics
– Medgenics
– GNS Healthcare
– Gerson Lehman Group
– Coatue Management
• Corporate Relationships
– Northrop Grumman
– Aptalis
– Thomson Reuters
– Intel
– SAP
– SV Angel
• Speakers’ bureau
– None
• Companies started by students
– Carmenta
– Serendipity
– NuMedii
– Stimulomics
– NunaHealth
– Praedicat
– MyTime
– Flipora
6. Already nearly 1.7 million microarrays publicly-available
Doubles every 2-3 years
Butte AJ. Translational Bioinformatics: coming of age. JAMIA, 2008.
12. 170 million substances x
1.1 million assays
More than a billion
measurements within a
grid of 190 trillion cells
122 million meet Lipinski 5
1 million active substances
13. • One example of a
microarray experiment
with diabetes and
control samples
• 187 genes differentially
expressed
Any one experiment does not yield
clear disease-causal factors
14.
15. Keiichi Kodama
Relativefrequency
# of positive RNA microarray experiments (out of 130)
Intersect 130 T2D microarray experiments
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
16. Keiichi Kodama
Relativefrequency
# of positive RNA microarray experiments (out of 130)
Intersect 130 T2D microarray experiments
Most of the 25000 genes in the
genome are positive in few T2D
microarray experiments
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
17. Keiichi Kodama
Relativefrequency
# of positive RNA microarray experiments (out of 130)
Intersect 130 T2D microarray experiments
TCF7L2
PPARG
IDE
LEPR
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
The 186 best known drug targets or
genes with DNA variants (from
GWAS) are positive in more
experiments
18. Keiichi Kodama
Close collaboration with Dr. Takashi Kadowaki, Momoko Horikoshi,
Kazuo Hara, University of Tokyo
Relativefrequency
# of positive RNA microarray experiments (out of 130)
Intersect 130 T2D microarray experiments
A
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
19. Keiichi Kodama
Gene A changes the most in adipose tissue
and islet cell experiments
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
20. Keiichi Kodama
Kyoko Toda
Gene A is higher in high fat diet
Gene A is expressed in mouse fat infiltrate
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
21. Gene A knockout has reduced infiltrate in fat
Keiichi Kodama
Kyoko Toda
• Mac-2 stain
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
22. Gene A knockout has increased insulin sensitivity
Keiichi Kodama
Kyoko Toda
• No change in weight gain
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
23. Keiichi Kodama
Inflammatory infiltrate in human fat
Protein of Gene A
• Paraffin-embedded omental adipose tissue from an
obese 57 year woman, BMI 36.9 kg/m2
• Analyzed for Protein A immunoreactivity
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
24. Keiichi Kodama
Momoko Horikoshi
Serum soluble Gene A protein
correlates with human HbA1c and insulin resistance
• n = 55 non-diabetics
• 60.3 years of age ± 15, 36 males, 19 females
• BMI 23.2 ± 4.3 kg/m2
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
26. Keiichi Kodama
Therapeutic antibody against Gene A reduces glucose
• C57BL6/6J fed high-fat diet for 18 weeks
• Intraperitoneal injection of rat anti-mouse anti-A antibody (n=8) or isotype
control (n=8)
• 100 μg at day 0 and 50 μg at day 1-7
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
27. Keiichi Kodama
• Gene A is CD44 (Hyaluronic Acid Receptor)
• Anti-CD44 in development for multiple cancers
• CD44 is a complicated receptor
Ponta, Sherman, Herrlich. Nature Reviews Molecular Cell Biology, 2003.
28. Longer-term trial of anti-CD44 as a prototype therapy for
type 2 diabetes
Kodama K, …, Butte AJ. Diabetes, 2015 Mar;64(3):867-75.
Keiichi Kodama
Kyoko Toda
Shojiroh Morinaga
Satoru Yamada
29. Anti-CD44 for 4 weeks reduces fasting glucose and
improves insulin sensitivity
Kodama K, …, Butte AJ. Diabetes, 2015 Mar;64(3):867-75.
Keiichi Kodama
Kyoko Toda
Shojiroh Morinaga
Satoru Yamada
30. Kodama K, …, Butte AJ. Diabetes, 2015 Mar;64(3):867-75.
Keiichi Kodama
Kyoko Toda
Shojiroh Morinaga
Satoru Yamada
Anti-CD44 for 4 weeks slows weight gain and reduces intake
31. Anti-CD44 for 4 weeks reduces adipose inflammation and
hepatic steatosis
Kodama K, …, Butte AJ. Diabetes, 2015 Mar;64(3):867-75.
Keiichi Kodama
Kyoko Toda
Shojiroh Morinaga
Satoru Yamada
32. Kodama K, …, Butte AJ. Diabetes, 2015.
Keiichi Kodama
Kyoko Toda
Shojiroh Morinaga
Satoru Yamada
37. Collaborators
• Jeff Wiser, Patrick Dunn, Mike Atassi / Northrop Grumman
• Ashley Xia and Quan Chen / NIAID
• Takashi Kadowaki, Momoko Horikoshi, Kazuo Hara, Hiroshi Ohtsu / U Tokyo
• Kyoko Toda, Satoru Yamada, Junichiro Irie / Kitasato Univ and Hospital
• Shiro Maeda / RIKEN
• Alejandro Sweet-Cordero, Julien Sage / Pediatric Oncology
• Mark Davis, C. Garrison Fathman / Immunology
• Russ Altman, Steve Quake / Bioengineering
• Euan Ashley, Joseph Wu, Tom Quertermous / Cardiology
• Mike Snyder, Carlos Bustamante, Anne Brunet / Genetics
• Jay Pasricha / Gastroenterology
• Rob Tibshirani, Brad Efron / Statistics
• Hannah Valantine, Kiran Khush/ Cardiology
• Ken Weinberg / Pediatric Stem Cell Therapeutics
• Mark Musen, Nigam Shah / National Center for Biomedical Ontology
• Minnie Sarwal / Nephrology
• David Miklos / Oncology
38. Support
• Lucile Packard Foundation for Children's Health
• NIH: NIAID, NLM, NIGMS, NCI; NIDDK, NHGRI, NIA, NHLBI, NCATS
• March of Dimes
• Hewlett Packard
• Howard Hughes Medical Institute
• California Institute for Regenerative Medicine
• Luke Evnin and Deann Wright (Scleroderma Research Foundation)
• Clayville Research Fund
• PhRMA Foundation
• Stanford Cancer Center, Bio-X, SPARK
• Tarangini Deshpande
• Sam Hawgood
• Keith Yamamoto
• Isaac Kohane
Admin and Tech Staff
• Mary Lyall
• Mounira Kenaani
• Kevin Kaier
• Boris Oskotsky